Thermo Fisher Scientific Inc. (TMO) CFO Stephen Williamson Sells 5,000 Shares

Thermo Fisher Scientific Inc. (NYSE:TMO) CFO Stephen Williamson sold 5,000 shares of the stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $209.26, for a total value of $1,046,300.00. Following the sale, the chief financial officer now directly owns 30,741 shares in the company, valued at approximately $6,432,861.66. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) traded down $8.82 during midday trading on Thursday, reaching $198.73. The company’s stock had a trading volume of 2,194,364 shares, compared to its average volume of 1,703,562. The company has a market cap of $84,000.52, a price-to-earnings ratio of 35.49, a P/E/G ratio of 1.53 and a beta of 1.11. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.35 and a quick ratio of 0.92. Thermo Fisher Scientific Inc. has a fifty-two week low of $151.74 and a fifty-two week high of $226.44.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping analysts’ consensus estimates of $2.66 by $0.13. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.72 billion. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. The company’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.41 EPS. sell-side analysts expect that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be paid a $0.17 dividend. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date is Wednesday, March 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.71%.

A number of analysts recently issued reports on the company. Barclays increased their price objective on Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Bank of America increased their price objective on Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Leerink Swann reissued an “outperform” rating and set a $239.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Thursday, February 1st. They noted that the move was a valuation call. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price objective on the stock in a report on Tuesday, October 31st. Finally, Morgan Stanley increased their price objective on Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Two research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $220.50.

A number of hedge funds and other institutional investors have recently made changes to their positions in TMO. Beach Investment Management LLC. increased its stake in Thermo Fisher Scientific by 1,702.8% in the 2nd quarter. Beach Investment Management LLC. now owns 71,661 shares of the medical research company’s stock worth $12,503,000 after acquiring an additional 67,686 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Thermo Fisher Scientific by 0.4% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,065 shares of the medical research company’s stock valued at $5,071,000 after purchasing an additional 106 shares during the last quarter. Synovus Financial Corp increased its position in shares of Thermo Fisher Scientific by 37.3% during the 2nd quarter. Synovus Financial Corp now owns 3,470 shares of the medical research company’s stock valued at $603,000 after purchasing an additional 943 shares during the last quarter. Rosenblum Silverman Sutton S F Inc. CA increased its position in shares of Thermo Fisher Scientific by 0.3% during the 2nd quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 43,958 shares of the medical research company’s stock valued at $7,669,000 after purchasing an additional 145 shares during the last quarter. Finally, Baltimore Capital Management Inc. bought a new position in shares of Thermo Fisher Scientific during the 2nd quarter valued at about $209,000. Institutional investors and hedge funds own 86.31% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Thermo Fisher Scientific Inc. (TMO) CFO Stephen Williamson Sells 5,000 Shares” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2018/02/08/thermo-fisher-scientific-inc-tmo-cfo-stephen-williamson-sells-5000-shares.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply